Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
US WorldMeds
US WorldMeds
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Corgard
Nadolol
1982-01-01
Angina pectoris
,
Heart failure
,
Hypertension
,
Myocardial infarction
Lucemyra
Lofexidine
2018-05-16
Substance withdrawal syndrome
Melphalan
Melphalan
2019-05-03
2029-2036
Hematopoietic stem cell transplantation
,
Hodgkin disease
,
Multiple myeloma
,
Myeloid leukemia acute
,
Neuroblastoma
,
Non-hodgkin lymphoma
,
Ovarian neoplasms
,
Precursor cell lymphoblastic leukemia-lymphoma
,
Breast neoplasms
,
Rhabdomyosarcoma
Revonto
Dantrolene
2007-07-24
2025
Cerebral infarction
,
Cerebral palsy
,
Malignant hyperthermia
,
Multiple sclerosis
,
Muscle spasticity
,
Neuroleptic malignant syndrome
,
Spinal cord injuries
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Lofexidine
opioid-related disorders
,
healthy volunteers/patients
,
neonatal abstinence syndrome
,
liver failure
,
substance withdrawal syndrome
Dexpramipexole
parkinson disease
Alfacalcidol
healthy volunteers/patients
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use